RD06-05

· Nanjing Bioheng Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RD06-05, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. [EARLY_Phase 1]

See pricing